Key Points
- Doximity CAO Siddharth Sitaram sold 2,613 shares for approximately $80,167 at an average price of $30.68. The sale was made under a pre-arranged Rule 10b5-1 plan to cover tax withholding, leaving him with 101,432 shares.
- Doximity reported quarterly revenue of $156.6 million, up 7.3% year over year, and adjusted earnings of $0.29 per share, beating analysts’ $0.16 consensus estimate.
- Analyst sentiment remains mixed, with the stock carrying a consensus “Hold” rating and an average price target of $30.73; eight analysts rate it Buy, 14 Hold, and three Sell.
Doximity, Inc. (NYSE:DOCS - Get Free Report) CAO Siddharth Sitaram sold 2,613 shares of the company's stock in a transaction on Wednesday, October 14th. The shares were sold at an average price of $30.68, for a total value of $80,166.84. Following the completion of the sale, the chief accounting officer owned 101,432 shares in the company, valued at $3,111,933.76. This represents a 2.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Siddharth Sitaram also recently made the following trade(s):
- On Tuesday, September 15th, Siddharth Sitaram sold 2,077 shares of Doximity stock. The stock was sold at an average price of $26.02, for a total value of $54,043.54.
- On Thursday, August 13th, Siddharth Sitaram sold 1,770 shares of Doximity stock. The stock was sold at an average price of $24.94, for a total value of $44,143.80.
Doximity Stock Performance
DOCS stock traded down $0.69 during trading on Friday, hitting $30.81. The stock had a trading volume of 3,582,714 shares, compared to its average volume of 3,332,407. The company's 50 day moving average price is $26.75 and its two-hundred day moving average price is $23.63. Doximity, Inc. has a 1-year low of $17.15 and a 1-year high of $71.37. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 36.25, a price-to-earnings-growth ratio of 24.64 and a beta of 1.22.
Doximity (NYSE:DOCS - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.13. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The company had revenue of $156.62 million for the quarter. During the same quarter last year, the company posted $0.36 earnings per share. Doximity's revenue for the quarter was up 7.3% on a year-over-year basis. As a group, sell-side analysts forecast that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several equities analysts recently issued reports on the stock. Piper Sandler reissued an "overweight" rating and set a $47.00 price objective (up from $42.00) on shares of Doximity in a research note on Friday, August 7th. Canaccord Genuity Group set a $36.00 target price on shares of Doximity in a research note on Friday, August 7th. Citigroup downgraded Doximity to an "underperform" rating in a report on Monday, June 29th. Truist Financial increased their price target on Doximity from $19.00 to $24.00 and gave the stock a "hold" rating in a research note on Thursday, August 13th. Finally, BMO Capital Markets reissued a "market perform" rating and set a $30.00 price target on shares of Doximity in a research note on Friday, August 7th. Eight research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $30.73.
Get Our Latest Report on DOCS
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Assenagon Asset Management S.A. acquired a new stake in shares of Doximity in the third quarter worth approximately $28,858,000. Fortitude Family Office LLC increased its position in Doximity by 31,271.4% during the third quarter. Fortitude Family Office LLC now owns 2,196 shares of the company's stock worth $62,000 after purchasing an additional 2,189 shares during the last quarter. Krilogy Financial LLC purchased a new position in Doximity during the third quarter worth approximately $220,000. Sax Wealth Advisors LLC purchased a new position in Doximity during the third quarter worth approximately $205,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Doximity by 19.8% in the 3rd quarter. GAMMA Investing LLC now owns 5,834 shares of the company's stock valued at $165,000 after purchasing an additional 963 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.
More Doximity News
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: Doximity extended its 13-year alliance with U.S. News, supporting physician searches, appointment booking and hospital rankings. The partnership could reinforce user engagement and patient-access offerings. Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
- Neutral Sentiment: Doximity will release fiscal 2027 second-quarter results on November 5, giving investors the next major opportunity to assess growth, advertising trends and management’s outlook. Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
- Negative Sentiment: Several law firms publicized a securities-fraud class action against Doximity and certain individuals, including co-founder and former Chief Strategy Officer Nate Gross. The allegations reportedly concern statements that Doximity could gain market share while older advertising formats were losing ground to programmatic and social-media competitors; the claims have not been established in court.
- Negative Sentiment: Investors who purchased DOCS shares between August 8, 2024 and May 13, 2026 are being reminded that November 16, 2026 is the deadline to seek appointment as lead plaintiff. Repeated announcements from Robbins Geller, SBS Law, Kaplan Fox, Rosen, Pomerantz, Bronstein Gewirtz Grossman and other firms increase the visibility of the legal overhang and could weigh on sentiment. DOCS Investor Alert
About Doximity
(
Get Free Report)
Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.
The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.
Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
